Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Point Of Care Diagnostics & Testing market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Point Of Care Diagnostics & Testing market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Point Of Care Diagnostics & Testing market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Point Of Care Diagnostics & Testing products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Point Of Care Diagnostics & Testing products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Point Of Care Diagnostics & Testing market.
To learn more about this report
Increasing research and development spending on Point Of Care Diagnostics & Testing development has been the leading industry trend of Point Of Care Diagnostics & Testing market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
| Report Attributes | Details |
| The market size value in 2021 | USD XX.XX Million |
| CAGR (2021 - 2028) | XX.XX % |
| The Revenue forecast in 2028 | USD XX.XX Million |
| Base year for estimation | 2021 |
| Historical data | 2018-2019 |
| Forecast period | 2022-2028 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook | Glucose Testing, Hb1Ac Testing, Coagulation, Fertility, Infectious Diseases, Cardiac Markers, Thyroid Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug Abuse Testing, Urinalysis |
| By Application Outlook | Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | F. Hoffmann-La Roche Ltd., Qiagen, Danaher Corp., Becton Dickinson (BD), Biomerieux SA, Abbott Laboratories, Siemens Healthcare AG, Zoetis, Inc., Instrumentation Laboratory, Nova Biomedical, Trividia Health, Inc., Quidel Corp., Trinity Biotech, Sekisui Diagnostics, Orasure Technologies, Inc., Nipro Corp., Spectral Medical, Inc. |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information Procurement
1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research
1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing
2 Executive Summary
3 Point Of Care Diagnostics & Testing Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator
3.2 Impact of COVID-19 Pandemic on Global Point Of Care Diagnostics & Testing Market
3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis
3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools
3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis
3.9 Key Company Ranking Analysis, 2020
4 Global Point Of Care Diagnostics & Testing Market Analysis and Forecast, By Type
4.1 Overview & Definition
4.2 Key Trends
4.3 Global Point Of Care Diagnostics & Testing Market Value (US$ Mn) Forecast, by Type (2019 – 2028)
4.2.1 Glucose Testing
4.2.2 Hb1Ac Testing
4.2.3 Coagulation
4.2.4 Fertility
4.2.5 Infectious Diseases
4.2.6 Cardiac Markers
4.2.7 Thyroid Stimulating Hormone
4.2.8 Hematology
4.2.9 Primary Care Systems
4.2.10 Decentralized Clinical Chemistry
4.2.11 Feces
4.2.12 Lipid Testing
4.2.13 Cancer Marker
4.2.14 Blood Gas/Electrolytes
4.2.15 Ambulatory Chemistry
4.2.16 Drug Abuse Testing
4.2.17 Urinalysis
4.4 Type Comparison Matrix
4.5 Global Point Of Care Diagnostics & Testing Market Attractiveness, By Type
5 Global Point Of Care Diagnostics & Testing Market Analysis and Forecast, By Application
5.1 Overview & Definition
5.2 Key Trends
5.3 Global Point Of Care Diagnostics & Testing Market Value (US$ Mn) Forecast, by Application (2019 – 2028)
5.3.1 Clinics
5.3.2 Hospitals
5.3.3 Home
5.3.4 Assisted Living Healthcare Facilities
5.3.5 Laboratory
5.4 Application Comparison Matrix
5.5 Global Point Of Care Diagnostics & Testing Market Attractiveness, by Application
6 Global Point Of Care Diagnostics & Testing Market Analysis and Forecast, By Region
6.1 Overview & Definition
6.2 Key Trends
6.3 Global Point Of Care Diagnostics & Testing Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa
7 Global Point Of Care Diagnostics & Testing Market Attractiveness, by Region
8 North America Point Of Care Diagnostics & Testing Market Analysis and Forecast
8.1 Key Findings
8.2 North America Point Of Care Diagnostics & Testing Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
8.2.1 Glucose Testing
8.2.2 Hb1Ac Testing
8.2.3 Coagulation
8.2.4 Fertility
8.2.5 Infectious Diseases
8.2.6 Cardiac Markers
8.2.7 Thyroid Stimulating Hormone
8.2.8 Hematology
8.2.9 Primary Care Systems
8.2.10 Decentralized Clinical Chemistry
8.2.11 Feces
8.2.12 Lipid Testing
8.2.13 Cancer Marker
8.2.14 Blood Gas/Electrolytes
8.2.15 Ambulatory Chemistry
8.2.16 Drug Abuse Testing
8.2.17 Urinalysis
8.3 North America Point Of Care Diagnostics & Testing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
8.3.1 Clinics
8.3.2 Hospitals
8.3.3 Home
8.3.4 Assisted Living Healthcare Facilities
8.3.5 Laboratory
8.4 North America Point Of Care Diagnostics & Testing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America
8.5 North America Point Of Care Diagnostics & Testing Market Attractiveness Analysis
8.5.1 By Type
8.5.2 By Application
8.5.3 By Country
9 Europe Point Of Care Diagnostics & Testing Market Analysis and Forecast
9.1 Key Findings
9.2 Europe Point Of Care Diagnostics & Testing Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
9.2.1 Glucose Testing
9.2.2 Hb1Ac Testing
9.2.3 Coagulation
9.2.4 Fertility
9.2.5 Infectious Diseases
9.2.6 Cardiac Markers
9.2.7 Thyroid Stimulating Hormone
9.2.8 Hematology
9.2.9 Primary Care Systems
9.2.10 Decentralized Clinical Chemistry
9.2.11 Feces
9.2.12 Lipid Testing
9.2.13 Cancer Marker
9.2.14 Blood Gas/Electrolytes
9.2.15 Ambulatory Chemistry
9.2.16 Drug Abuse Testing
9.2.17 Urinalysis
9.3 Europe Point Of Care Diagnostics & Testing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
9.3.1 Clinics
9.3.2 Hospitals
9.3.3 Home
9.3.4 Assisted Living Healthcare Facilities
9.3.5 Laboratory
9.4 Europe Point Of Care Diagnostics & Testing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Europe Point Of Care Diagnostics & Testing Market Attractiveness Analysis
9.5.1 By Type
9.5.2 By Application
9.5.3 By Country
10 Asia Pacific Point Of Care Diagnostics & Testing Market Analysis and Forecast
10.1 Key Findings
10.2 Asia Pacific Point Of Care Diagnostics & Testing Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
10.2.1 Glucose Testing
10.2.2 Hb1Ac Testing
10.2.3 Coagulation
10.2.4 Fertility
10.2.5 Infectious Diseases
10.2.6 Cardiac Markers
10.2.7 Thyroid Stimulating Hormone
10.2.8 Hematology
10.2.9 Primary Care Systems
10.2.10 Decentralized Clinical Chemistry
10.2.11 Feces
10.2.12 Lipid Testing
10.2.13 Cancer Marker
10.2.14 Blood Gas/Electrolytes
10.2.15 Ambulatory Chemistry
10.2.16 Drug Abuse Testing
10.2.17 Urinalysis
10.3 Asia Pacific Point Of Care Diagnostics & Testing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
10.3.1 Clinics
10.3.2 Hospitals
10.3.3 Home
10.3.4 Assisted Living Healthcare Facilities
10.3.5 Laboratory
10.4 Asia Pacific Point Of Care Diagnostics & Testing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Asia Pacific Point Of Care Diagnostics & Testing Market Attractiveness Analysis
10.5.1 By Type
10.5.2 By Application
10.5.3 By Country
11 Latin America Point Of Care Diagnostics & Testing Market Analysis and Forecast
11.1 Key Findings
11.2 Latin America Point Of Care Diagnostics & Testing Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
11.2.1 Glucose Testing
11.2.2 Hb1Ac Testing
11.2.3 Coagulation
11.2.4 Fertility
11.2.5 Infectious Diseases
11.2.6 Cardiac Markers
11.2.7 Thyroid Stimulating Hormone
11.2.8 Hematology
11.2.9 Primary Care Systems
11.2.10 Decentralized Clinical Chemistry
11.2.11 Feces
11.2.12 Lipid Testing
11.2.13 Cancer Marker
11.2.14 Blood Gas/Electrolytes
11.2.15 Ambulatory Chemistry
11.2.16 Drug Abuse Testing
11.2.17 Urinalysis
11.3 Latin America Point Of Care Diagnostics & Testing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
11.3.1 Clinics
11.3.2 Hospitals
11.3.3 Home
11.3.4 Assisted Living Healthcare Facilities
11.3.5 Laboratory
11.4 Latin America Point Of Care Diagnostics & Testing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
11.4.1 Brazil
11.4.2 Rest of Latin America China
11.5 Latin America Point Of Care Diagnostics & Testing Market Attractiveness Analysis
11.5.1 By Type
11.5.2 By Application
11.5.3 By Country
12 Middle East & Africa (MEA) Point Of Care Diagnostics & Testing Market Analysis and Forecast
12.1 Key Findings
12.2 Middle East & Africa (MEA) Point Of Care Diagnostics & Testing Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)
12.2.1 Glucose Testing
12.2.2 Hb1Ac Testing
12.2.3 Coagulation
12.2.4 Fertility
12.2.5 Infectious Diseases
12.2.6 Cardiac Markers
12.2.7 Thyroid Stimulating Hormone
12.2.8 Hematology
12.2.9 Primary Care Systems
12.2.10 Decentralized Clinical Chemistry
12.2.11 Feces
12.2.12 Lipid Testing
12.2.13 Cancer Marker
12.2.14 Blood Gas/Electrolytes
12.2.15 Ambulatory Chemistry
12.2.16 Drug Abuse Testing
12.2.17 Urinalysis
12.3 Middle East & Africa (MEA) Point Of Care Diagnostics & Testing Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
12.3.1 Clinics
12.3.2 Hospitals
12.3.3 Home
12.3.4 Assisted Living Healthcare Facilities
12.3.5 Laboratory
12.4 Middle East & Africa (MEA) Point Of Care Diagnostics & Testing Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA
12.5 Middle East & Africa (MEA) Point Of Care Diagnostics & Testing Market Attractiveness Analysis
12.5.1 By Type
12.5.2 By Application
12.5.3 By Country
13 Competitive Landscape
13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles
13.3.1 F. Hoffmann-La Roche Ltd.
13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies
13.3.2 Qiagen
13.3.3 Danaher Corp.
13.3.4 Becton Dickinson (BD)
13.3.5 Biomerieux SA
13.3.6 Abbott Laboratories
13.3.7 Siemens Healthcare AG
13.3.8 Zoetis
13.3.9 Inc.
13.3.10 Instrumentation Laboratory
13.3.11 Nova Biomedical
13.3.12 Trividia Health
13.3.13 Inc.
13.3.14 Quidel Corp.
13.3.15 Trinity Biotech
13.3.16 Sekisui Diagnostics
13.3.17 Orasure Technologies
13.3.18 Inc.
13.3.19 Nipro Corp.
13.3.20 Spectral Medical
13.3.21 Inc.
14 Key Takeaways
Choose License Type